A serum biomarker panel and miniarray detection system for tracking disease activity and flare risk in lupus nephritis
BPMA-S6 may represent a promising point-of-care test (POCT) for the diagnosis, disease monitoring, and assessment of LN flare.
Authors
- Richard D. Williams (ORCID: https://orcid.org/0000-0002-7710-2975)
- Ramesh Saxena (ORCID: https://orcid.org/0000-0001-5722-9509)
- Tianfu Wu (ORCID: https://orcid.org/0000-0001-8235-5929)
- Jing Ning (ORCID: https://orcid.org/0000-0001-9739-6563)
- Gongjun Tan (ORCID: https://orcid.org/0000-0003-4603-4014)
- Chenling Tang (ORCID: https://orcid.org/0000-0001-9037-1179)
- Weihang Zhu (ORCID: https://orcid.org/0000-0002-6092-1608)
- Aygun Teymur
- Jiechang Guo
- Arturo Haces-Garcia
Institutions
- nLIGHT (United States) (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Houston (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1541907
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- National Institutes of Health